~~<i id='8288F1DFF6'><strike id='8288F1DFF6'><tt id='8288F1DFF6'><pre id='8288F1DFF6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

comprehensive

author：entertainment 2025-10-01 14:19:31 - browse：4

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Who are the detained American citizens released from prison in Iran?

hotspot

focus

knowledge

entertainment

focus

1:00PresidentialcandidateFernandoVillavicenciospeaksduringacampaigneventataschoolminutesbeforehewass

WSS

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Target recalls 2.2 million additional candles due to laceration, burn hazards

The science behind Janet Jackson's pregnancy at 49

Death of patient in Alzheimer’s trial raises question of possible risks

Novo acquires Inversago for up to $1 billion

Newly revealed memo details efforts to keep Trump in power following election loss

entertainment

comprehensive

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Some of the ways extreme heat will change life as we know it

What does generative AI mean for health care? We asked experts

Listen: Your guide to Wegovy's blockbuster heart study

How to save PrEP access — and even expand it

Donald Trump's relentless attacks on special counsel Jack Smith

The cancer drug shortage isn’t new — and neither are the solutions

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Medicare details structure of new drug price negotiation program

Colonoscopy at 40? Study finds a possible benefit

focus

Timeline: Special counsel's investigation into Trump's handling of classified documents

White House drug shortages task force keeps mum with Congress

Why drug prescriptions should include diagnoses

Why we need to separate burnout from moral injury in health care

New guidelines on severe brain injury complicate already difficult decisions

Some of the ways extreme heat will change life as we know it

knowledge

entertainment

focus

focus